English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Apr 10, 2026
Heartland Institute's Milloy on vaccine liability: 'Simply ending immunity on vaccines will only make things worse'
Patient Daily
| Apr 10, 2026
Cornell Health Policy Center survey: 78% of experts say weakening vaccine liability protections would curb innovation
Patient Daily
| Apr 9, 2026
Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
Patient Daily
| Apr 8, 2026
Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
A. D. Brady
| Mar 30, 2026
Consumer Choice Advocate: RFK Jr. helped ‘dubious claims gain credibility in courtrooms’
Patient Daily
| Mar 30, 2026
Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
Patient Daily
| Mar 30, 2026
Biotechnology Innovation Organization survey finds strong voter support for PBM reforms
Patient Daily
| Mar 27, 2026
Texas Attorney General announces agreement with Crest on children’s toothpaste packaging
Trending
Patient Daily
| Apr 7, 2026
ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+
Pharmaceuticals
Patient Daily
| Apr 5, 2026
Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
+
Regulatory
Patient Daily
| Apr 9, 2026
Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+
Regulatory
Patient Daily
| Apr 8, 2026
Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
1
2
»
Last »
